XENE Stock Analysis: Buy, Sell, or Hold?
XENE - Xenon Pharmaceuticals Inc
$41.01
-0.75 (-1.80%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When XENE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: XENE shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: XENE shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: XENE is currently trading at $41.01, which is considered slightly low relative to its 30-day fair value range of $40.80 to $43.84.
Technical Outlook: Technically, XENE is in a uptrend. Immediate support is located at $39.29, while resistance sits at $43.70.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $55.51 (+32.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XENE is in a uptrend. Immediate support is located at $39.29, while resistance sits at $43.70.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $55.51 (+32.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$40.80 -
$43.84
Company Quality Score
59/100
(HOLD)
Options IV Signal
59th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 59th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 32.9% below Wall St target ($55.51)
Fair Price Analysis
30-Day Fair Range
$40.80 -
$43.84
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$7.48
(18.2%)
Support & Resistance Levels
Support Level
$39.29
Resistance Level
$43.70
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-9.08
Wall Street Target
$55.51
(+32.9%)
Revenue Growth (YoY)
-100.0%
Last updated: January 31, 2026 12:04 AM ET
Data refreshes hourly during market hours. Next update: 1:04 AM
Data refreshes hourly during market hours. Next update: 1:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XENE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Ian Mortimer
SELL
25000 shares
2025-10-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced XENE Option Strategies
Professional options setups generated by AI based on today's XENE price and gamma walls.